Two COVID-19 treatments that have not yet been authorized for administration were successful in clinical trials, the companies behind the drugs announced on April 11.
A pill developed to attack cancer was successful in curbing deaths among COVID-19 patients in hospitals deemed high risk for Acute Respiratory Distress Syndrome, according to U.S.-based Veru Inc., the maker of the drug.
